The presence of hyponatremia in a patient with end-stage liver disease is associated with increased mortality. Kim et al proposed the MELDNa score to reflect this risk. The authors are from the Mayo Clinic, University of California San Francisco and the United Network for Organ Sharing (UNOS).

To read more or access our algorithms and calculators, please log in or register.